Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with other antiretrovirals for the treatment of HIV-1 infection. It binds to reverse transcriptase, inhibiting HIV replication. It is grouped under the following drug class(es): Reverse Transcriptase Inhibitors. Its therapeutic use is listed as anti-infectives and antivirals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Intelence and etravirinum. Its PubChem CID is 193962.
Etravirine
| CAS No | 269055-15-4 |
|---|---|
| Molecular Formula | C20H15BrN6O |
| Molecular Weight | 435.3 g/mol |
| Synonyms | 4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with other antiretrovirals for the treatment of HIV-1 infection. It binds to reverse transcriptase, inhibiting HIV replication.
The listed CAS number is 269055-15-4.
The listed molecular formula is C20H15BrN6O.
The listed molecular weight is 435.3 g/mol.
4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile.
The source lists Intelence and etravirinum.